Are Celgene Corp.’s Shares About to Get Hammered? | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 1 June, 2015 by The TZ Newswire Staff

Are Celgene Corp.’s Shares About to Get Hammered?

A push to radically lower the cost of cancer drugs could cause revenues to crater for cancer specialists.

See also
- Next Article Movers & Shakers: Vascular Biogenics soars on positive trial; Pier 1 slides on downgrade
- Previous Article The Wall Street Journal: CA hires new tech chief in bid for spark growth
Editorial Calender

June 2015

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar